ArticleBlood cancer journal2022

Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia.

Cheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.